The use of anti-idiotype (Id) antibodies as vaccines to stimulate antitumor immunity is one of several promising immunologic approaches to the therapy of cancer. Extensive studies in animal tumor models have demonstrated the efficacy of anti-Id vaccines in preventing tumor growth and curing mice with established tumors. A number of monoclonal anti-Id antibodies that mimic distinct human tumor-associated antigens (TAAs) have been developed and tested in the clinic and demonstrate encouraging results. Creative Biolabs is a world leader in the field of cancer vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best development services for anti-idiotype vaccines. We guarantee the finest results for our customers all over the world.